Crapo expresses concern over agency accountability.
05/18/2015
https://www.congress.gov...
When we talk about the need for greater transparency in the drug supply chain, that term can and should mean a few diffe...
I hope you will continue to be transparent, accessible, and willing to work with me and my colleagues.
I strongly suggest you accelerate your timeline and return to this committee in short order with an actual plan.
In many ways, Medicare Part D reflects an unprecedented success story, coming in massively under budget, with low and st...